The case of 23andMe outlines many of the open challenges related to taking advantage of computational tools in combination with sensitive personal information such as genetic data. Read or listen to the full article at https://www.theatlantic.com/health/archive/2024/09/23andme-dna-data-privacy-sale/680057/